MacKay Kimberly Banks
SEC CIK 1835699 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| WST | West Pharmaceutical Services | SVP, GC, Corp. Sec | 1,512 | — | — | 5 | 2022-02-22 | 2025-02-18 |
Most active insiders at WST, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Favorite Annette F | SVP, Chief HR Off | — | $6.30M |
| 2 | Winters Chad | VP, CAO | — | $269.4K |
| 3 | Poussot Rodolphe Jean | SVP, Strategy, Corp. Dev | — | — |
| 4 | Campbell Shane Alden | SVP, Proprietary Segment | — | — |
| 5 | Lockhart Stephen H | Dir | — | — |
| 6 | Witherspoon Charles | VP, Treas | — | — |
| 7 | Joseph Molly | Dir | — | — |
| 8 | McMahon Robert W. | SVP, CFO | — | — |
| 9 | Feehery William F | Dir | — | — |
| 10 | Pucci Paolo | Dir | — | — |
MacKay Kimberly Banks made no open-market trades at WST in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-20 | 2025-02-18 | WST | West Pharmaceutical Services | MacKay Kimberly Banks | SVP, GC, Corp. Sec | F - Tax | $211.00 | -92.69 | 1,512 | -6% | -$19.6K |
| D | 2025-02-20 | 2025-02-18 | WST | West Pharmaceutical Services | MacKay Kimberly Banks | SVP, GC, Corp. Sec | M - OptEx | $211.00 | +246.16 | 1,605 | +18% | +$51.9K |
| D | 2024-02-22 | 2024-02-20 | WST | West Pharmaceutical Services | MacKay Kimberly Banks | SVP, GC, Corp. Sec | A - Grant | $0.00 | +720 | 1,358 | +113% | $0 |
| D | 2023-02-23 | 2023-02-21 | WST | West Pharmaceutical Services | MacKay Kimberly Banks | SVP, GC, Corp. Sec | A - Grant | $306.68 | +327 | 637 | +105% | +$100.3K |
| 2022-02-24 | 2022-02-22 | WST | West Pharmaceutical Services | MacKay Kimberly Banks | SVP, GC, Corp. Sec | M - OptEx | $369.13 | +310 | 310 | New | +$114.4K |
Purchase Sale Sale after option exercise All abbreviations